• 16428 Citations
  • 63 Scopus h-Index
19962019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Susan L Slager is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Single Nucleotide Polymorphism Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Genome-Wide Association Study Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Genes Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2002 2016

B-Cell Chronic Lymphocytic Leukemia
Genome
Genome-Wide Association Study
Survival
Molecular Epidemiology
B-Cell Chronic Lymphocytic Leukemia
Chromosomes
Pedigree
Genome-Wide Association Study
Neoplasm Genes
Genetic Research
Registries
Case-Control Studies
Molecular Biology

Research Output 1996 2019

Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare

Hampel, P. J., Call, T. G., Ding, W., Muchtar, E., Kenderian, S. S., Wang, Y., Leis, J. F., Witzig, T. E., Koehler, A. B., Fonder, A. L., Schwager, S. M., Rabe, K. G., Van Dyke, D. L., Braggio, E., Slager, S. L., Kay, N. E. & Parikh, S. A., Jan 1 2019, (Accepted/In press) In : American journal of hematology.

Research output: Contribution to journalLetter

Open Access

Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma

Wang, Y., Wenzl, K., Manske, M. K., Asmann, Y., Sarangi, V., Greipp, P. T., Krull, J. E., Hartert, K., He, R., Feldman, A. L., Maurer, M. J., Slager, S. L., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Link, B. K., Ansell, S. M., Cerhan, J. R. & Novak, A. J., Sep 1 2019, In : Blood cancer journal. 9, 9, 73.

Research output: Contribution to journalArticle

Open Access
Lymphoma, Large B-Cell, Diffuse
B-Cell Lymphoma
Immunotherapy
Lymphoma
Hodgkin Disease

Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Clay-Gilmour, A. I., Rishi, A. R., Goldin, L. R., Greenberg-Worisek, A. J., Achenbach, S. J., Rabe, K. G., Maurer, M. J., Kay, N. E., Shanafelt, T. D., Call, T. G., Brice Weinberg, J., Camp, N. J., Cerhan, J. R., Leis, J., Norman, A., Murray, D. L., Vincent Rajkumar, S., Caporaso, N. E., Landgren, O., McMaster, M. L. & 2 others, Slager, S. L. & Vachon, C. M., Aug 5 2019, In : Blood cancer journal. 9, 8, 1 p.

Research output: Contribution to journalArticle

Open Access
Lymphocytosis
B-Cell Chronic Lymphocytic Leukemia
Light
B-Lymphocytes
Logistic Models

Blood transfusion history and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis

Cerhan, J. R., Kane, E., Vajdic, C. M., Linet, M. S., Monnereau, A., Bernstein, L., de Sanjose, S., Chiu, B. C. H., Spinelli, J. J., Maso, L. D., Zhang, Y., Larrabee, B. R., Cozen, W., Smith, A. G., Clavel, J., Serraino, D., Zheng, T., Holly, E. A., Weisenberger, D. D., Slager, S. L. & 1 others, Bracci, P. M., Jan 1 2019, In : Cancer Causes and Control.

Research output: Contribution to journalArticle

Blood Transfusion
Non-Hodgkin's Lymphoma
History
Odds Ratio
Confidence Intervals
11 Citations (Scopus)

Cause of death in follicular lymphoma in the first decade of the rituximab era: A pooled analysis of French and US cohorts

Sarkozy, C., Maurer, M. J., Link, B. K., Ghesquieres, H., Nicolas, E., Thompson, C. A., Traverse-Glehen, A., Feldman, A. L., Allmer, C., Slager, S. L., Ansell, S. M., Habermann, T. M., Bachy, E., Cerhan, J. R. & Salles, G., Jan 10 2019, In : Journal of Clinical Oncology. 37, 2, p. 144-152 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Cause of Death
Lymphoma
Disease-Free Survival
Rituximab